ArticleClinical drug investigation2017
Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan.
Chieh-Yu Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it